Inconsistent alignment with WHO TRS during WHO inspection – avoiding repeat WHO observations


Published on 28/01/2026

Addressing Inconsistent Alignment with WHO TRS Observations During Inspections

As pharmaceutical manufacturers, consistency with World Health Organization (WHO) technical reports and guidelines is crucial for maintaining compliance during inspections. Inconsistencies can lead to repeated observations, creating significant hurdles during WHO inspections and impacting your Quality Management System (QMS). This article provides a playbook for addressing these issues effectively. By following this guide, professionals in manufacturing, quality control, quality assurance, engineering, and regulatory affairs will be better equipped to diagnose discrepancies, implement corrective actions, and prepare for inspections.

To understand the bigger picture and long-term care, read this WHO GMP Compliance.

This playbook covers actionable strategies across different roles to ensure that your operations align with WHO Technical Report Series (TRS) expectations, thereby preventing repeat observations and enhancing overall compliance. You will learn how to identify symptoms, investigate issues, execute containment actions, and prepare for an inspection-ready review.

Symptoms/Signals on the Floor or in the Lab

Identifying symptoms of inconsistent alignment with WHO TRS during

manufacturing or laboratory operations is crucial for timely intervention. Some common signals include:

  • Increased Deviations: Frequent deviations from standard operating procedures (SOPs) noted in deviation logs.
  • Quality Control Failures: Consistent failure to meet quality specifications in laboratory test results, particularly during stability testing.
  • Staff Confusion: Reports from staff indicating uncertainty or lack of training related to WHO guidelines.
  • Unusual Findings: Non-conformities that do not align with historical data or previous compliance validations.

Prompt identification of these symptoms facilitates timely containment and thorough investigation, minimizing potential negative impacts on product quality and regulatory standing.

Likely Causes

Understanding the root causes of inconsistencies with WHO TRS involves examining several categories: Materials, Method, Machine, Man, Measurement, and Environment. Below is a detailed overview:

Category Potential Causes
Materials Use of substandard raw materials, improper storage conditions, or supplier issues.
Method Outdated procedures, non-compliance with WHO TRS, or use of unsuitable testing methods.
Machine Equipment malfunctions, calibration failures, or maintenance oversights.
Man Lack of training or awareness regarding WHO TRS, resulting in improper implementation of protocols.
Measurement Inconsistent measurement techniques or laboratory errors during testing phases.
Environment Improper control of environmental conditions such as temperature and humidity during manufacturing.
Pharma Tip:  WHO GMP gap identified during prequalification preparation – gap remediation roadmap

By understanding these likely causes, teams can focus on specific areas for investigation and remediation efforts.

Immediate Containment Actions (first 60 minutes)

When discrepancies are identified, immediate containment actions are essential to mitigate potential impacts. The following steps should be executed within the first hour:

  1. Stop Production: If a significant deviation is detected, halting production may be necessary to prevent further issues.
  2. Isolate Affected Materials/Batch: Identify and segregate impacted batches or materials to prevent distribution.
  3. Notify Key Stakeholders: Inform the quality assurance team and senior management about the issue for rapid information dissemination.
  4. Document Initial Findings: Record any initial observations, including symptoms and immediate actions taken, to form a foundation for further investigation.
  5. Compile Data: Assemble relevant documentation, including batch records, equipment logs, and involved personnel statements.

Investigation Workflow (data to collect + how to interpret)

Executing a structured investigation workflow ensures comprehensive analysis of the situation. The following framework can be utilized:

  1. Define the Problem: Clearly articulate the observed discrepancy, specifying its nature and potential impact on compliance and product quality.
  2. Collect Data: Review batch records, testing data, equipment logs, and personnel training records to identify patterns or anomalies relevant to the inconsistency.
  3. Engage a Cross-Functional Team: Form a team comprising members from production, quality control, engineering, and regulatory affairs to leverage diverse expertise in analysis.
  4. Analyze Data: Look for correlations between the data collected and the noted discrepancies. Utilize statistical tools if necessary to assess patterns.
  5. Document Findings: Maintain clear and organized records of findings, methodologies, and discussions for regulatory review.

Interpretation should focus on identifying causal relationships and potential systemic weakness in the processes. Identifying trends will help guide corrective measures and preventive actions.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Employing root cause analysis tools is critical for uncovering underlying issues. Here are three effective methods and their applications:

  • 5-Why Analysis: A simple iterative questioning technique useful for exploring the cause-and-effect relationships underlying a problem. It mainly focuses on human-related causes and is straightforward to implement during team discussions.
  • Fishbone Diagram: Also known as the Ishikawa diagram, this tool helps in categorizing potential causes into structured groups, making it particularly useful in group settings to identify various factors like Man, Method, Machine, etc.
  • Fault Tree Analysis: A more complex evaluation that uses a top-down approach to detail potential failures within processes or systems. Best suited for intricate systems with multiple contributors to failures.
Pharma Tip:  Documentation not aligned to WHO during remediation planning – avoiding repeat WHO observations

Select the root cause tool based on the complexity of the issue and the information available. Starting with a broader tool like the Fishbone diagram may uncover various factors worth exploring further with the 5-Why technique.

CAPA Strategy (correction, corrective action, preventive action)

Formulating a Corrective and Preventive Action (CAPA) strategy is vital for mitigating risks associated with repeated WHO TRS observations. This strategy should involve:

  1. Correction: Implement corrective measures to address the immediate cause of the observed issue. This might involve re-training staff, recalibrating equipment, or revising SOPs.
  2. Corrective Action: Identify long-term changes needed to rectify systemic issues contributing to non-compliance. This could include revising material specifications or enhancing process validations.
  3. Preventive Action: Develop proactive measures that aim to prevent the recurrence of the same issues. Regular audits and training updates can help embed these preventive measures.

Document each aspect of the CAPA strategy, emphasizing the relationship between observed issues, implemented actions, and anticipated outcomes. This documentation is vital for compliance verification.

Related Reads

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

Maintaining an effective control strategy is essential in ensuring ongoing compliance with WHO TRS. Consider the following elements for control and monitoring:

  • Statistical Process Control (SPC): Implement SPC techniques to monitor critical process parameters through control charts, ensuring no deviations occur.
  • Regular Trending: Analyze historical data for trends that might indicate a looming issue before it becomes significant.
  • Defined Sampling Plans: Establish a robust sampling strategy—considering sample size, frequency, and method of analysis—to ensure comprehensive monitoring.
  • Alarm Systems: Use alarm thresholds in critical control points to provide real-time notifications about potential deviations.
  • Document Verification Processes: Have clear procedures to consistently verify product quality before release, tying back to documented evidence from previous CAPA actions.

Implement these controls as part of the ongoing operational procedures to align closer to WHO TRS requirements.

Validation / Re-qualification / Change Control Impact (when needed)

Changes to any process, equipment, or materials that led to inconsistencies must be treated systematically through validation, re-qualification, and change control processes. Key considerations include:

  • Validation Strategy: Develop a comprehensive validation protocol that verifies the effectiveness of remedial actions taken.
  • Re-qualification Needs: If equipment or processes are significantly altered, re-qualification may be necessary to affirm alignment with WHO TRS standards.
  • Change Control Protocols: Utilize established change control processes to manage modifications, ensuring that all changes are documented, assessed, and approved accordingly.
Pharma Tip:  API site WHO GMP risk during WHO inspection – evidence pack for WHO audits

Focusing on these areas enhances compliance stability and mitigates risks of future observations.

Inspection Readiness: What Evidence to Show (records, logs, batch docs, deviations)

Preparation for inspections should involve comprehensive documentation and evidence to demonstrate compliance with WHO TRS. Key documents to prepare include:

  • Records: Ensure all manufacturing and testing records are complete, coherent, and accessible, reflecting real-time operations.
  • Logs: Maintain meticulous equipment logs, showing timely maintenance and calibration activities, and document any incidents related to observed failures.
  • Batch Documentation: Have complete batch records available that demonstrate adherence to the validated processes and include results of quality control checks.
  • Deviation Reports: Proper documentation of all deviations, including investigations and CAPA, showing your response and preventive measures taken.

Being equipped with detailed records serves to support your compliance status during WHO inspections, addressing any past observations effectively.

FAQs

What are WHO TRS guidelines?

WHO TRS guidelines provide standards and recommendations aimed at ensuring quality in pharmaceutical products, outlining expectations for compliance and operational excellence.

How can I improve our CAPA processes?

Improving CAPA processes can be achieved through regular training, employee participation in casual discussions, utilizing effective root cause analysis tools, and regularly reviewing processes.

What roles are involved in ensuring compliance?

Key roles include production staff, quality control analysts, quality assurance personnel, regulatory affairs specialists, and engineering teams – all of whom must collaborate to maintain compliance.

How often should we conduct compliance audits?

Compliance audits should ideally be conducted quarterly, with additional audits as needed based on previous inspection outcomes or recent changes in processes.

What is a deviation report?

A deviation report is a documented account of non-conformities that have occurred during manufacturing or testing, detailing the nature of the deviation, its impact, and subsequent corrective actions.

Why is statistical process control important?

Statistical process control is critical as it allows for the monitoring of processes continuously, detecting variations before they lead to significant non-compliance issues.

What should be included in our training program on WHO compliance?

Training programs should cover WHO TRS guidelines, SOPs, the importance of quality compliance, and regular updates on changes in regulatory requirements.

How can we increase staff awareness about WHO requirements?

Regular training sessions, internal newsletters, and informal discussion forums can help increase staff awareness and understanding of WHO requirements and quality practices.